Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Furmark

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Translational Psychiatry|August 30, 2018
Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traitsJohanna M Hoppe, Andreas Frick, Fredrik Åhs, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 24, 2012
Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorderVanda Faria, Lieuwe Appel, Fredrik Åhs, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 25, 2016
Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trialMalin Gingnell, Andreas Frick, Jonas Engman, et al.
Neuroscience Letters|September 27, 2014
Enlargement of visual processing regions in social anxiety disorder is related to symptom severityAndreas Frick, Jonas Engman, Iman Alaie, et al.
JAMA Psychiatry|June 18, 2015
Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography StudyAndreas Frick, Fredrik Åhs, Jonas Engman, et al.
Translational Psychiatry|October 6, 2022
Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapyOlof Hjorth, Andreas Frick, Malin Gingnell, et al.
Molecular Psychiatry|December 12, 2019
Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography studyOlof R Hjorth, Andreas Frick, Malin Gingnell, et al.
Behavioural Brain Research|January 21, 2023
Dorsal anterior cingulate cortex activity during cognitive challenge in social anxiety disorderMagdalena Wlad, Andreas Frick, Jonas Engman, et al.
Biological Psychiatry|July 26, 2005
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placeboTomas Furmark, Lieuwe Appel, Asa Michelgård, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 5, 2008
A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxietyTomas Furmark, Lieuwe Appel, Susanne Henningsson, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Translational Psychiatry|August 30, 2018
Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traitsJohanna M Hoppe, Andreas Frick, Fredrik Åhs, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 24, 2012
Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorderVanda Faria, Lieuwe Appel, Fredrik Åhs, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 25, 2016
Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trialMalin Gingnell, Andreas Frick, Jonas Engman, et al.
Neuroscience Letters|September 27, 2014
Enlargement of visual processing regions in social anxiety disorder is related to symptom severityAndreas Frick, Jonas Engman, Iman Alaie, et al.
JAMA Psychiatry|June 18, 2015
Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography StudyAndreas Frick, Fredrik Åhs, Jonas Engman, et al.
Translational Psychiatry|October 6, 2022
Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapyOlof Hjorth, Andreas Frick, Malin Gingnell, et al.
Molecular Psychiatry|December 12, 2019
Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography studyOlof R Hjorth, Andreas Frick, Malin Gingnell, et al.
Behavioural Brain Research|January 21, 2023
Dorsal anterior cingulate cortex activity during cognitive challenge in social anxiety disorderMagdalena Wlad, Andreas Frick, Jonas Engman, et al.
Biological Psychiatry|July 26, 2005
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placeboTomas Furmark, Lieuwe Appel, Asa Michelgård, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 5, 2008
A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxietyTomas Furmark, Lieuwe Appel, Susanne Henningsson, et al.
Pageof 10